ABO blood group and incidence of epithelial ovarian cancer

被引:88
作者
Gates, Margaret A. [1 ,2 ,3 ]
Wolpin, Brian M. [2 ,4 ]
Cramer, Daniel W. [2 ,3 ,5 ]
Hankinson, Susan E. [1 ,2 ,3 ]
Tworoger, Shelley S. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
ovarian neoplasms; ABO blood group; cohort studies; prospective studies; GROUP ANTIGENS; RISK;
D O I
10.1002/ijc.25339
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have observed an association between ABO blood group and risk of certain malignancies, including ovarian cancer; however, no prospective studies of the association with ovarian cancer risk are available. Using data from 49,153 women in the Nurses' Health Study, we examined the association between ABO blood group and incidence of epithelial ovarian cancer. Study participants reported their blood type and Rh factor in 1996, and 234 women were diagnosed with incident ovarian cancer during 10 years of follow-up. We used Cox proportional hazards regression to model the incidence rate ratios (RR) and 95% confidence intervals (CI) of ovarian cancer for each blood group category. Compared to women with blood group O, women with blood group AB or B had a nonsignificant 38% increase in ovarian cancer incidence (95% CI = 0.88-2.16 for blood group AB and 0.96-1.99 for blood group B), whereas blood group A was not associated with risk (RR = 0.95, 95% CI = 0.70-1.30). Combining blood groups AB and B, we observed a statistically significant positive association with presence versus absence of the B antigen overall (RR = 1.41, 95% CI = 1.06-1.88) and for the serous invasive subtype (RR = 1.53, 95% CI = 1.08-2.17). In this large, prospective cohort of women, presence of the B antigen was positively associated with ovarian cancer incidence, whereas blood group A was not associated with risk. Additional studies are needed to confirm this association and to explore the mechanisms through which blood group may influence ovarian cancer risk.
引用
收藏
页码:482 / 486
页数:5
相关论文
共 50 条
  • [41] Maternal ABO blood group and adverse pregnancy outcomes
    C Phaloprakarn
    S Tangjitgamol
    Journal of Perinatology, 2013, 33 : 107 - 111
  • [42] ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity
    Stakisaitis, Donatas
    Jukneviciene, Milda
    Ulys, Albertas
    Zaliuniene, Dalia
    Stanislovaitiene, Daiva
    Sepetiene, Ramune
    Slavinska, Anzelika
    Suziedelis, Kestutis
    Lesauskaite, Vita
    ONCOLOGY LETTERS, 2018, 16 (01) : 1321 - 1331
  • [43] Review of ABO Expression and Variations based on Transcriptional Regulation of the ABO Blood Group Gene
    Ogasawara, Kenichi
    Sano, Rie
    Kominato, Yoshihiko
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (04) : 210 - 224
  • [44] Hemostasis, cancer, and ABO blood group: the most recent evidence of association
    Liumbruno, Giancarlo Maria
    Franchini, Massimo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (02) : 160 - 166
  • [45] Hemostasis, cancer, and ABO blood group: the most recent evidence of association
    Giancarlo Maria Liumbruno
    Massimo Franchini
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 160 - 166
  • [46] A systematic review of prognosis of ABO blood group and rhesus factor on outcomes in patients with bladder cancer
    Yang, Haiming
    Yan, Jingxin
    MEDICINE, 2022, 101 (39) : E30893
  • [47] Influence of ABO blood group on susceptibility to different pathological types of lung cancer: a retrospective study
    Yang, Haotian
    Zeng, Xianjun
    Zhang, Yu
    Tong, Weilai
    Yao, Geliang
    Lan, Chunyu
    Liu, Jiaming
    Liu, Zhili
    Zhong, Nanshan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [48] The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer
    Massimo Franchini
    Giuseppe Lippi
    BMC Medicine, 13
  • [49] A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer
    Xie, Jing
    Poole, Elizabeth M.
    Terry, Kathryn L.
    Fung, Teresa T.
    Rosner, Bernard A.
    Willett, Walter C.
    Tworoger, Shelley S.
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [50] Blood group determinates incidence for pancreatic cancer in Germany
    Pelzer, U.
    Klein, F.
    Bahra, M.
    Sinn, M.
    Doerken, B.
    Neuhaus, P.
    Meyer, O.
    Riess, H.
    FRONTIERS IN PHYSIOLOGY, 2013, 4